|
FOXK2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.178000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.681300E-03 |
| Normal-vs-Stage2 |
4.363900E-03 |
| Normal-vs-Stage3 |
4.804200E-02 |
| Normal-vs-Stage4 |
6.164400E-03 |
| Stage1-vs-Stage2 |
4.171200E-01 |
| Stage1-vs-Stage3 |
1.294780E-01 |
| Stage1-vs-Stage4 |
9.336600E-01 |
| Stage2-vs-Stage3 |
1.038450E-01 |
| Stage2-vs-Stage4 |
5.141000E-01 |
| Stage3-vs-Stage4 |
2.226000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.623700E-03 |
| Normal-vs-AfricanAmerican |
5.080600E-03 |
| Normal-vs-Asian |
2.377600E-03 |
| Caucasian-vs-AfricanAmerican |
2.642600E-01 |
| Caucasian-vs-Asian |
2.097400E-01 |
| AfricanAmerican-vs-Asian |
8.895200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.501000E-03 |
| Normal-vs-Female |
3.141300E-03 |
| Male-vs-Female |
9.271200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.736770E-03 |
| Normal-vs-Age(41-60Yrs) |
1.326330E-02 |
| Normal-vs-Age(61-80Yrs) |
1.027690E-02 |
| Normal-vs-Age(81-100Yrs) |
8.295000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.151200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.332000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.122200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.317200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.541800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.660800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.828000E-02 |
| Classical-VS-Follicular |
1.181610E-02 |
| Classical-VS-Other |
3.188400E-01 |
| Classical-VS-Normal |
9.59480000000124E-05 |
| Tall-VS-Follicular |
7.348600E-01 |
| Tall-VS-Other |
8.260200E-01 |
| Tall-VS-Normal |
1.441400E-01 |
| Follicular-VS-Other |
9.909800E-01 |
| Follicular-VS-Normal |
2.281200E-01 |
| Other-VS-Normal |
5.317600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.270010E-02 |
| Normal-vs-N1 |
4.923800E-02 |
| N0-vs-N1 |
7.543000E-01 |
|
|
